Hui An
Wenzhou, 325035, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Correction: Chen et al. Glutathione Induces Keap1 S-Glutathionylation and Mitigates Oscillating Glucose-Induced β-Cell Dysfunction by Activating Nrf2. Antioxidants 2024, 13, 400.
Journal: Antioxidants (Basel, Switzerland)
Published: December 19, 2025
Persistent lymphocytopenia in convalescent patients with COVID-19: dysregulated B cell, CD4+ T cell, and treg compartments in 7-12% of moderate-severe cases.
Journal: Frontiers in cellular and infection microbiology
Published: August 27, 2025
Unveiling the hidden link: elevated platelets and T cell subsets in 5% of moderate COVID-19 patients 48 days post-onset.
Journal: Frontiers in cellular and infection microbiology
Published: September 19, 2024
Persistent CD19+ B cell lymphopenia in critically ill COVID-19 patients 50 days after symptom onset.
Persistent CD19+ B cell lymphopenia in critically ill COVID-19 patients 50 days after symptom onset.
Journal: Frontiers in cellular and infection microbiology
Published: August 30, 2024
Glutathione Induces Keap1 S-Glutathionylation and Mitigates Oscillating Glucose-Induced β-Cell Dysfunction by Activating Nrf2.
Journal: Antioxidants (Basel, Switzerland)
Published: March 03, 2024
Glutathione prevents high glucose-induced pancreatic fibrosis by suppressing pancreatic stellate cell activation via the ROS/TGFβ/SMAD pathway.
Journal: Cell death & disease
Published: December 05, 2021
Inflammation/Coagulopathy/Immunology Responsive Index Predicts Poor COVID-19 Prognosis.
Journal: Frontiers in cellular and infection microbiology
Published: November 02, 2021
Inflammation/coagulopathy/fibrinolysis: Dynamic indicators of COVID-19 progression in patients with moderate COVID-19 in Wenzhou, China.
Journal: Clinical immunology (Orlando, Fla.)
Published: March 17, 2021
Sex- and age-specific clinical and immunological features of coronavirus disease 2019.
Journal: PLoS pathogens
Published: December 18, 2020
Glutathione prevents chronic oscillating glucose intake-induced β-cell dedifferentiation and failure.
Journal: Cell death & disease
Published: February 05, 2019
Showing 1-11 of 11
Last Updated: 09/26/2026